Natural Killer Cells Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00008500
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Natural Killer Cells Therapeutics Market Scope and Key Players Analysis by 2031

Buy Now

Natural Killer Cells Therapeutics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Therapeutics
  • NK Cell Therapies
  • NK Cell Directed Antibodies
By Application
  • Cancer
  • Gastrointestinal Diseases
  • Immunoproliferative Disorders
By End User
  • Research Centers and Institutes
  • Hospitals
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Affimed GmbH
  • Celgene Corporation
  • Fate Therapeutics
  • Fortress Biotech Inc
  • Glycostem Therapeutics B V
  • Innate Pharma S A
  • Nantkwest Inc
  • Nkarta Therapeutics Inc
  • NKT Therapeutics Inc